Meyer Philippe, Bouhours Hugo, Dehaynin Nicolas, Jarnet Delphine, Gantier Matthieu, Karamanoukian Diran, Niederst Claudine
Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France.
Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France.
Phys Med. 2015 Jul;31(5):542-52. doi: 10.1016/j.ejmp.2015.05.005. Epub 2015 May 29.
To determine the optimum combination of treatment parameters between pitch, field width (FW) and modulation factor (MF) for extremity sarcomas in tomotherapy.
Six patients previously treated for extremity sarcomas (3 arms and 3 legs) with tomotherapy were included in this study. 288 treatment plans were recalculated, corresponding to all combinations between 2 FW (2.5 and 5 cm), 4 MF (1.5, 2, 2.5 and 3) and 6 pitches (0.215, 0.287, 0.43 and 3 off-axis pitches). The treatment parameters (MF, FW or pitch) are modified between each plan, and the calculation is relaunched for 400 iterations, without modifying the optimisation constraints of the plan under which the patient has been treated.
We suggest eliminating the 0.43 pitch and never combining a 0.215 pitch with an MF ≤ 2. We also do not recommend using an MF = 1.5 unless treatment time is an absolute priority over plan quality. We did not see any advantage in using Chen off-axis pitches, except for targets far from the axis (>15 cm) treated with a high pitch. A combination of MF = 2/FW = 5 cm/pitch = 0.287 gives plans of acceptable quality, combined with reduced treatment times. These conclusions are true only for extremity sarcomas treated in 2 Gy/fraction.
We have shown that the choice of pitch/MF/FW combination is crucial for the treatment of extremity sarcomas in tomotherapy: some produce good dosimetric quality with a reduced irradiation time, while others may increase the time without improving the quality.
确定螺旋断层放射治疗肢体肉瘤时,螺距、射野宽度(FW)和调强因子(MF)之间的最佳治疗参数组合。
本研究纳入6例曾接受螺旋断层放射治疗的肢体肉瘤患者(3例上肢和3例下肢)。重新计算了288个治疗计划,对应2种射野宽度(2.5 cm和5 cm)、4种调强因子(1.5、2、2.5和3)以及6种螺距(0.215、0.287、0.43和3种非共面螺距)之间的所有组合。每个计划之间修改治疗参数(调强因子、射野宽度或螺距),并重新进行400次迭代计算,不修改患者已接受治疗计划的优化约束条件。
我们建议排除0.43的螺距,并且0.215的螺距绝不要与调强因子≤2联合使用。除非治疗时间绝对优先于计划质量,否则我们也不建议使用调强因子=1.5。除了用高螺距治疗远离中心轴(>15 cm)的靶区外,我们未发现使用陈式非共面螺距有任何优势。调强因子=2/射野宽度=5 cm/螺距=0.287的组合可产生质量可接受的计划,同时缩短治疗时间。这些结论仅适用于采用2 Gy/分次治疗的肢体肉瘤。
我们已经表明,螺距/调强因子/射野宽度组合的选择对于螺旋断层放射治疗肢体肉瘤至关重要:一些组合可产生良好的剂量学质量并缩短照射时间,而其他组合可能会增加时间却无法提高质量。